CARGO Therapeutics, Inc. Common Stock
CRGX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $7,830 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $572 | $1,220 | $1,363 | $1,773 |
| Gross Profit | -$572 | -$1,220 | -$1,363 | -$1,773 |
| % Margin | – | – | -17.4% | – |
| R&D Expenses | $7,509 | $30,637 | $39,504 | $35,932 |
| G&A Expenses | $8,292 | $11,508 | $10,630 | $11,180 |
| SG&A Expenses | $8,292 | $11,508 | $10,630 | $11,180 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $37,098 | $46,280 | -$1,363 | $0 |
| Operating Expenses | $52,899 | $88,425 | $48,771 | $47,112 |
| Operating Income | -$52,899 | -$88,425 | -$50,134 | -$47,112 |
| % Margin | – | – | -640.3% | – |
| Other Income/Exp. Net | $2,962 | $3,927 | $4,699 | $5,204 |
| Pre-Tax Income | -$49,937 | -$84,498 | -$45,435 | -$41,908 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$49,937 | -$84,498 | -$45,435 | -$41,908 |
| % Margin | – | – | -580.3% | – |
| EPS | -1.04 | -1.77 | -0.99 | -0.88 |
| % Growth | 41.2% | -78.8% | -12.5% | – |
| EPS Diluted | -1.04 | -1.77 | -0.99 | -0.88 |
| Weighted Avg Shares Out | 48,134 | 47,852 | 46,043 | 47,664 |
| Weighted Avg Shares Out Dil | 48,134 | 47,852 | 46,043 | 47,664 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,269 | $3,938 | $4,668 | $5,403 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $572 | $1,220 | $1,363 | $1,784 |
| EBITDA | -$15,229 | -$40,925 | -$44,072 | -$40,124 |
| % Margin | – | – | -562.9% | – |